Results 261 to 270 of about 40,750 (280)

Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial

Lancet, The, 2019
Shammi L Ramlakhan, Carrol Gamble, Shrouk Messahel   +2 more
exaly  

Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial

Lancet, The, 2019
Stuart R Dalziel, Meredith L Borland, Jeremy S Furyk   +2 more
exaly  

Levetiracetam

Reactions Weekly, 2011
openaire   +2 more sources

Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy

European Journal of Pharmacology, 1998
Alain Matagne
exaly  

Clinical Pharmacokinetics of Levetiracetam

Clinical Pharmacokinetics, 2012
Philip N Patsalos
exaly  

Review: Is levetiracetam different from other antiepileptic drugs? Levetiracetam and its cellular mechanism of action in epilepsy revisited

Therapeutic Advances in Neurological Disorders, 2008
Rainer Surges, Kirill E Volynski
exaly  

Levetiracetam Psychosis in Children with Epilepsy

Epilepsia, 2001
Eric H Kossoff
exaly  

Levetiracetam

Reactions Weekly, 2015
openaire   +1 more source

Pharmacokinetic Study of Levetiracetam in Children

Epilepsia, 2001
Tracy A Glauser, Nathan B Fountain
exaly  

Benefit of combination therapy in epilepsy: A review of the preclinical evidence with levetiracetam

Epilepsia, 2009
Alain Matagne, Philip N Patsalos
exaly